Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1971-10-26
1976-11-02
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
A61K 3512, A61K 3556
Patent
active
039898199
ABSTRACT:
There is described a process for the preparation and separation of components from central nervous system tissue by sequential chromatography; wherein certain components contain proteins of a weight average molecular weight of 8,000 to 10,000 and are highly encephalitogenic while others have weight average molecular weights in the range of 2,000 to 4,000 and exhibit weaker encephalitogenic activity, and in addition, a method of treating experimentally induced diseases by administering said low molecular weight components is described.
REFERENCES:
merck Manual, 12th Edition, 1972, pp. 1339-1342.
Chemical Abstracts, vol. 53, 16348a (1959).
American Cyanamid Company
Drezin Norman A.
Richards Jack W.
LandOfFree
Process for separating proteins from central nervous system tiss does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for separating proteins from central nervous system tiss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for separating proteins from central nervous system tiss will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1160014